Exelixis Newsroom

Leerink Partners Maintains Exelixis(EXEL.US) With Hold Rating

Futu NewsDec 3 15:32

RBC Capital Sticks to Their Buy Rating for Exelixis (EXEL)

TipRanksNov 28 09:49

A Quick Look at Today's Ratings for Exelixis(EXEL.US), With a Forecast Between $29 to $38

Futu NewsOct 31 21:17

Exelixis Price Target Raised to $36.00/Share From $32.00 by Wells Fargo

Dow JonesOct 30 23:11

Exelixis Is Maintained at Outperform by BMO Capital

Dow JonesOct 30 22:07

Exelixis Analyst Ratings

BenzingaOct 30 21:57

A Quick Look at Today's Ratings for Exelixis(EXEL.US), With a Forecast Between $29 to $38

Futu NewsOct 30 21:14

Exelixis Analyst Ratings

BenzingaOct 22 01:17

TD Cowen Maintains Exelixis(EXEL.US) With Buy Rating, Raises Target Price to $34

Futu NewsOct 21 19:34

Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), Korro Bio (KRRO) and Vertex Pharmaceuticals (VRTX)

TipRanksOct 21 18:58

A Quick Look at Today's Ratings for Exelixis(EXEL.US), With a Forecast Between $30 to $34

Futu NewsOct 17 21:06

A Quick Look at Today's Ratings for Exelixis(EXEL.US), With a Forecast Between $27 to $34

Futu NewsOct 16 21:03

Morgan Stanley Lifts Price Target on Exelixis to $30 From $28, Keeps Equalweight Rating

MT NewswiresOct 16 19:37

Exelixis Is Maintained at Market Outperform by JMP Securities

Dow JonesOct 16 19:30

Goldman Sachs Remains a Sell on Exelixis (EXEL)

TipRanksOct 16 10:55

Exelixis Hold Rating: Navigating Legal Wins and Strategic Acquisitions Amid Uncertain Revenue Transition

TipRanksOct 16 04:27

Exelixis Analyst Ratings

BenzingaOct 16 01:47

Citi Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $31

Futu NewsOct 15 20:33

Truist Financial Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $33

Futu NewsOct 15 19:32

Truist Financial Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $33

Futu NewsOct 15 14:32